These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 37685507)

  • 1. Reply to Fernandez-Vigo et al. Comment on "Torrellas et al. Effectiveness, Safety and Choroidal Changes of a Fovea-Sparing Technique for the Treatment of Chronic Central Serous Chorioretinopathy with Yellow Subthreshold Laser.
    Torrellas B; Filloy A; Wu L; Chhablani J; Romero-Aroca P
    J Clin Med; 2023 Aug; 12(17):. PubMed ID: 37685507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment on Torrellas et al. Effectiveness, Safety and Choroidal Changes of a Fovea-Sparing Technique for the Treatment of Chronic Central Serous Chorioretinopathy with Yellow Subthreshold Laser.
    Fernandez-Vigo JI; Enríquez-Fuentes JE; Oribio-Quinto C; Alarcón-García AD; Moreno-Morillo FJ; Donate-López J
    J Clin Med; 2023 Jun; 12(13):. PubMed ID: 37445337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness, Safety and Choroidal Changes of a Fovea-Sparing Technique for the Treatment of Chronic Central Serous Chorioretinopathy with Yellow Subthreshold Laser.
    Torrellas B; Filloy A; Wu L; Chhablani J; Romero-Aroca P
    J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reply to Stanojcic et al. Comment on "Fernández-Vigo et al. Objective Classification of Glistening in Implanted Intraocular Lenses Using Optical Coherence Tomography: Proposal for a New Classification and Grading System.
    Fernández-Vigo JI; Burgos-Blasco B; De-Pablo-Gómez-de-Liaño L; Sánchez-Guillén I; Albitre-Barca V; Fernández-Aragón S; Fernández-Vigo JÁ; Macarro-Merino A
    J Clin Med; 2023 May; 12(11):. PubMed ID: 37297882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reply to Marino et al. Does Subretinal Fluid Influence Choroidal Thickness (ChT) and Structure in Preeclampsia with Serous Retinal Detachment? Comment on "Fukui et al. Changes in Choroidal Thickness and Structure in Preeclampsia with Serous Retinal Detachment.
    Fukui A; Tanaka H; Terao N; Nagata K; Matsumoto A; Kusada N; Kojima K; Sotozono C
    J Clin Med; 2023 May; 12(9):. PubMed ID: 37176714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment on Fernández-Vigo et al. Objective Classification of Glistening in Implanted Intraocular Lenses Using Optical Coherence Tomography: Proposal for a New Classification and Grading System.
    Stanojcic N; Hull C; O'Brart D
    J Clin Med; 2023 May; 12(11):. PubMed ID: 37297881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reply to Marino et al. Choroidal Thickness Measurements in the Case of Diabetic Macular Edema. Comment on "Amjad et al. Choroidal Thickness in Different Patterns of Diabetic Macular Edema.
    Amjad R; Lee CA; Farooqi HMU; Khan H; Paeng DG
    J Clin Med; 2023 Apr; 12(8):. PubMed ID: 37109214
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does Subretinal Fluid Influence Choroidal Thickness (ChT) and Structure in Preeclampsia with Serous Retinal Detachment? Comment on Fukui et al. Changes in Choroidal Thickness and Structure in Preeclampsia with Serous Retinal Detachment.
    Marino AV; La Marca A; De Luca M; D'Aniello E; Gioia M
    J Clin Med; 2023 May; 12(9):. PubMed ID: 37176713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reply to Ayuso García et al. Health Perception among Female COVID-19 Patients. Comment on "Fernández-de-las-Peñas et al. Female Sex Is a Risk Factor Associated with Long-Term Post-COVID Related-Symptoms but Not with COVID-19 Symptoms: The LONG-COVID-EXP-CM Multicenter Study.
    Fernández-de-Las-Peñas C; Martín-Guerrero JD; Pellicer-Valero ÓJ; Navarro-Pardo E; Gómez-Mayordomo V; Cuadrado ML; Arias-Navalón JA; Cigarán-Méndez M; Hernández-Barrera V; Arendt-Nielsen L
    J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35806901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reply to Böning et al. Comment on "Ceruti et al. Temporal Changes in the Oxyhemoglobin Dissociation Curve of Critically Ill COVID-19 Patients.
    Ceruti S; Minotti B; Glotta A; Biggiogero M; Bona G; Marzano M; Greco P; Spagnoletti M; Garzoni C; Bendjelid K
    J Clin Med; 2022 Aug; 11(15):. PubMed ID: 35956162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy of subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy.
    Uzlu D; Erdöl H; Kola M; Özbay AD
    Lasers Med Sci; 2021 Jul; 36(5):981-988. PubMed ID: 32812130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term efficacy of subthreshold micropulse yellow laser (577-nm) photocoagulation for chronic central serous chorioretinopathy.
    Kim JY; Park HS; Kim SY
    Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2129-35. PubMed ID: 25717024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reply to van der Pluijm et al. Comment on "Weitzman et al. Resistance to Antimalarial Monotherapy Is Cyclic.
    Calfon-Peretz O; Weitzman R; Amitay M; Samson AO
    J Clin Med; 2022 May; 11(11):. PubMed ID: 35683361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reply to Cione et al. Comment on "Moshirfar et al. Accuracy of Six Intraocular Lens Power Calculations in Eyes with Axial Lengths Greater than 28.0 mm.
    Moshirfar M; Durnford KM; Jensen JL; Beesley DP; Peterson TS; Darquea IM; Ronquillo YC; Hoopes PC
    J Clin Med; 2023 May; 12(9):. PubMed ID: 37176708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two protocols of subthreshold micropulse yellow laser treatment for non-resolving central serous chorioretinopathy.
    Beniwal A; Shaikh N; Chawla R; Azad SV; Kumar V; Vohra R
    Indian J Ophthalmol; 2022 Sep; 70(9):3341-3345. PubMed ID: 36018117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reply to Brea et al. Comment on "Levitt et al. Approach to Decompensated Right Heart Failure in the Acute Setting.
    Levitt CV; Williams CA; Ahari J; Pourmand A
    J Clin Med; 2024 Jun; 13(13):. PubMed ID: 38999415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sclerobanding Is a Novel Technique for the Treatment of Second- and Third-Degree Hemorrhoidal Disease. Reply to Jongen et al. Comment on "Pata et al. Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes.
    Pata F; Bracchitta LM; D'Ambrosio G; Bracchitta S
    J Clin Med; 2022 May; 11(11):. PubMed ID: 35683464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reply to Kielb et al. Untapped Potential for Female Patients? Comment on "Lucà et al. Update on Management of Cardiovascular Diseases in Women.
    Lucà F; Colivicchi F; Rossini R; Riccio C; Gelsomino S; Gulizia MM
    J Clin Med; 2022 May; 11(11):. PubMed ID: 35683475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subthreshold yellow laser for fovea-involving diabetic macular edema in a series of patients with good vision: effectiveness and safety of a fovea-sparing technique.
    Filloy A; Chong V; Solé E
    BMC Ophthalmol; 2020 Jul; 20(1):266. PubMed ID: 32631268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reply to Chen et al. Improvements in Outcomes and Expanding Indications for the Commando Procedure. Comment on "Giambuzzi et al. Surgical Aortic Mitral Curtain Replacement: Systematic Review and Metanalysis of Early and Long-Term Results.
    Giambuzzi I; Bonalumi G; Di Mauro M; Alamanni F; Zanobini M
    J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35329926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.